Comment
doi: 10.1038/clpt.2012.234.
Epub 2012 Dec 6.
Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?"
- PMID: 23340478
- DOI: 10.1038/clpt.2012.234
Item in Clipboard
Comment
Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?"
Clin Pharmacol Ther.
2013 Apr.
No abstract available
Comment on
-
In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.Clin Pharmacol Ther. 2012 Sep;92(3):366-75. doi: 10.1038/clpt.2012.109. Epub 2012 Aug 8. Clin Pharmacol Ther. 2012. PMID: 22871995
-
Pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?Clin Pharmacol Ther. 2013 Apr;93(4):306-7. doi: 10.1038/clpt.2012.214. Epub 2012 Oct 24. Clin Pharmacol Ther. 2013. PMID: 23299646 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
